Health Care & Life Sciences » Biotechnology | Accelerate Diagnostics Inc.

Accelerate Diagnostics Inc.

Accelerate Diagnostics Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
54.13 M
Public Float
29.72 M
Accelerate Diagnostics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.65
Market Cap
$1.28 B
Shares Outstanding
54.46 M
Public Float
29.78 M

Profile

Address
3950 South Country Club Road
Tucson Arizona 85714
United States
Employees -
Website http://acceleratediagnostics.com
Updated 07/08/2019
Accelerate Diagnostics, Inc. is an in vitro diagnostics company, which engages in the provision of solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. It also focuses on developing and commercializing innovative instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company was founded on May 26, 1982 and is headquartered in Tucson, AZ.

Financials

View All
Created with Highcharts 5.0.14Accelerate Diagnostics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.15 28115 28130 93330 93345 49845 49866 37466 37464 02864 02888 32688 326201320142015201620172018020k40k60k80k100k
Created with Highcharts 5.0.14Accelerate Diagnostics Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.48481221221471472462464 1774 1775 6705 67020132014201520162017201801k2k3k4k5k6k

Lawrence L. Mehren
President, Chief Executive Officer & Director
John Patience
Chairman